|
|
Volumn 41, Issue 6, 2009, Pages 2137-2138
|
|
Evaluation of the Efficacy and Safety of Conversion to Sirolimus in 85 Renal Transplant Recipients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
CREATININE;
CYCLOSPORIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ERYTHROPOIETIN;
EZETIMIBE;
FIBRIC ACID DERIVATIVE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RAPAMYCIN;
STEROID;
TACROLIMUS;
ALOPECIA;
ANEMIA;
ARTICLE;
CHRONIC ALLOGRAFT NEPHROPATHY;
CREATININE CLEARANCE;
DIARRHEA;
DISEASE COURSE;
DRUG DOSE INCREASE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
EDEMA;
GRAFT SURVIVAL;
HEMOLYTIC UREMIC SYNDROME;
HUMAN;
HYPERGLYCEMIA;
HYPERLIPIDEMIA;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY FUNCTION;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LIPID BLOOD LEVEL;
LYMPHOPROLIFERATIVE DISEASE;
MAJOR CLINICAL STUDY;
MOUTH ULCER;
ORGAN TRANSPLANTATION;
PNEUMONIA;
PRIORITY JOURNAL;
PROTEINURIA;
RETROSPECTIVE STUDY;
SKIN TUMOR;
TREATMENT OUTCOME;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
FOLLOW-UP STUDIES;
HUMANS;
HYPERTENSION;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
POSTOPERATIVE COMPLICATIONS;
PROTEINURIA;
RETROSPECTIVE STUDIES;
SAFETY;
SIROLIMUS;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 68949217712
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2009.06.101 Document Type: Article |
|
Times cited : (4)
|
|
References (4)
|
